Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMPEDIMED LIMITED Capital/Financing Update 2019

Jun 24, 2019

65135_rns_2019-06-24_17263c68-ee81-48d6-a9f3-c9305ebc4fb5.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Market Announcement

==> picture [33 x 50] intentionally omitted <==

25 June 2019

==> picture [451 x 5] intentionally omitted <==

ImpediMed Limited (ASX: IPD) – Trading Halt

Description

The securities of ImpediMed Limited (‘IPD’) will be placed in trading halt at the request of IPD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 27 June 2019 or when the announcement is released to the market.

Issued by

Adrian Smythe

Manager, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

25 June 2019 ASX Limited

==> picture [215 x 71] intentionally omitted <==

25 June 2019

Ms Lisa Banh Senior Adviser, Listings Compliance ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000

Dear Ms Banh,

Pursuant to ASX Listing Rule 17.1, ImpediMed Limited (ASX: IPD) ( ImpediMed ) requests an immediate trading halt be granted by ASX Limited with respect to its shares from the commencement of trading on Tuesday 25 June 2019 .

The trading halt is requested in connection with a capital raising.

The following information is provided in accordance with Listing Rule 17.1:

  1. Reason for trading halt – to avoid trading taking place on an uninformed basis and to allow the capital raising to take place in an orderly manner.

  2. Duration of the trading halt – ImpediMed expects that the trading halt will last until it makes an announcement to ASX concerning the outcome of the proposed capital raising, which it expects to make before the commencement of trading on Thursday 27 June 2019.

  3. Termination of trading halt – ImpediMed anticipates that the trading halt will cease upon the commencement of normal trading on Thursday 27 June 2019.

  4. No reason – ImpediMed is not aware of any reason why the trading halt should not be granted.

  5. Further information – none.

Should you have any questions, please do not hesitate to contact me on +61 414 731 082.

Yours sincerely,

Leanne Ralph Company Secretary

ImpediMed, Inc. ● TEL: +1 (760) 585 2100

FAX: +1 (760) 804 9245 ● FREE CALL: +1 77 247 0111 ● EMAIL: [email protected]